Viracta Therapeutics, Inc. reports

Company location: Cardiff, CA
Fiscal year end: 31 December

Viracta Therapeutics, Inc. has filed 1,181 SEC EDGAR filings since 07 Aug 2002

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 201-225 of 861 matching filings.

Per page

25

Current page

9

4

FORM 4 SUBMISSION

Filing date: 30 Mar 2021
Reporting date: 26 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Mar 2021
Reporting date: 26 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Mar 2021
Reporting date: 26 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Mar 2021
Reporting date: 26 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Mar 2021
Reporting date: 26 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Mar 2021
Reporting date: 26 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Mar 2021
Reporting date: 26 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Mar 2021
Reporting date: 26 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Mar 2021
Reporting date: 26 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 30 Mar 2021
Reporting date: 26 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-51531

8-K

Filing date: 23 Mar 2021
Reporting date: 22 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K/A File 000-51531

8-K/A

Filing date: 23 Mar 2021
Reporting date: 24 Feb 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13D/A File 005-81034

NEW ENTERPRISE ASSOCIATES 12, LP (VIRACTA) - SCHEDULE 13DA5E

Filing date: 11 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-81034

SC 13G

Filing date: 08 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-81034

FORM SC 13G AMENDMENT 1

Filing date: 05 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Mar 2021
Reporting date: 03 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 04 Mar 2021
Reporting date: 03 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-51531

8-K

Filing date: 04 Mar 2021
Reporting date: 03 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D File 005-81034

SC 13D

Filing date: 02 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 25 Feb 2021
Reporting date: 24 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 25 Feb 2021
Reporting date: 24 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Feb 2021
Reporting date: 24 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Feb 2021
Reporting date: 24 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Feb 2021
Reporting date: 24 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3 SUBMISSION

Filing date: 24 Feb 2021
Reporting date: 24 Feb 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .